Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin augmentation of group social skills training in male adolescents with autism spectrum disorder
2010-024202-34Phase 3Completed
- Sponsor
- Universitätsmedizin Göttingen
- Start
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of oxytocin in Autism Spectrum Disorder (ASD) (2 arms), sponsored by Universitätsmedizin Göttingen. Primary endpoint: Primary efficacy endpoint. Started Dec 2013; status: completed.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on 2010-024202-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024202-34.